Epigenome editing therapeutics for chronic diseases
- HQ
- Durham
- Sector
- biotech
- Stage
- series_b
- Total raised
- $175M
- Last round
- series_b
Founder profiles, enrichment notes, funding history, and investor connections are available to signed-in members.
Sign in to view full record